home / stock / aplt / aplt news

APLT News and Press, Applied Therapeutics Inc. From 02/16/24

Stock Information
Company Name: Applied Therapeutics Inc.
Stock Symbol: APLT
Market: NYSE
Website: appliedtherapeutics.com
Menu
APLT APLT Quote APLT Short APLT News APLT Articles APLT Message Board
Get APLT Alerts

News, Short Squeeze, Breakout and More Instantly...
APLT - APLT, BMR and TCTM among mid-day movers

2024-02-16 12:29:21 ET Gainers: Pop Culture Group Co Ltd ( CPOP ) +176% . Fusion Fuel Green Ltd ( HTOO ) +127% . MicroCloud Hologram ( HOLO ) +118% . Nano X Imaging Ltd ( NNOX ) +48% . MoneyHero Ltd ( MNY ) +46% . Tarena Inte...
APLT - Applied Therapeutics New 52-Week High Following Yesterday's Govorestat News

2024-02-16 10:08:37 ET DENVER, Colo., Feb 16, 2024 (www.247marketnews.com)- Applied Therapeutics, Inc. (NASDAQ: APLT ) reported, yesterday morning, positive interim 12-month results from the ongoing Phase 3 INSPIRE trial, in which the primary endpoints and several key secondary endpoint...

APLT - APLT, BLZE and CORZZ are among after hour movers

2024-02-15 17:12:12 ET Gainers: The Trade Desk ( TTD ) +20% . Applied Materials ( AMAT ) +11% . Coinbase Global ( COIN ) +11% . Backblaze ( BLZE ) +9% . Texas Roadhouse ( TXRH ) +6% . Losers: Roku ( ROKU ) -16% . ...

APLT - American Well, West Pharmaceutical Services among healthcare movers

2024-02-15 10:00:00 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...
APLT - APLT Reports Positive Phase 3 Trial Results from Interim Analysis of Govorestat

2024-02-15 09:29:01 ET DENVER, Colo., Feb 15, 2024 (www.247marketnews.com) – Applied Therapeutics, Inc. (NASDAQ: APLT ) reported, this morning, achieving primary endpoints and several key secondary endpoints in its interim 12-month results from the ongoing Phase 3 INSPIRE trial, ...

APLT - Applied Therapeutics gains as late-stage trial for lead asset succeeds

2024-02-15 08:24:49 ET More on Applied Therapeutics Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade) ARISE-HF Phase 3 Trial Likely To Disappoint Due To Multiple Red Flags Applied Therapeutics: Multiple Inflection Points Could Gene...

APLT - Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency

Interim primary endpoint met; Statistically significant correlation of sorbitol with the CMT-FOM clinical outcome composite (p=0.05) Sustained, statistically significant reduction in sorbitol in govorestat-treated patients vs. placebo (p<0.001) Highly statistically significan...
APLT - Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade)

2024-01-08 08:19:00 ET Summary APLT had a considerable run-up since my prior coverage. APLT remains undervalued based on just the galactosemia thesis. However, now the short-term risk has increased considerably, for numerous reasons. AT-001 failed to meet the primary endpoint...

APLT - PETS, NVTS and GRTS are among after hour movers

2024-01-05 16:47:44 ET Gainers: Credo Technology Group Holding  ( CRDO ) +3% . Gritstone  ( GRTS ) +3% . PetMed Express ( PETS ) +3% . Navitas Semiconductor Corporation ( NVTS ) +2% . Intuitive Machines ( LUNR ) +2% . ...

APLT - RCAC, AIMD and MESO among mid-day movers

2024-01-05 12:31:54 ET Gainers: Revelstone Capital Acquisition Corp ( RCAC ) +90% . Ainos ( AIMD ) +72% . Banzai International ( BNZI ) +62% . Safe and Green Development ( SGD ) +41% . Swvl Holdings ( SWVL ) +41% . Zoomcar Ho...
Previous 10 Next 10